Roche buys gene sequencing firm

Roche (RHHBY) acquires privately-held U.S. gene sequencing company Genia Technologies for as much as $350M. The deal involves $125M up front and as much as $225M in contingent payments depending on certain milestones.

Genia's value proposition is low cost sequencing. It uses cheap electronic semiconductors in its platform instead of optical sensors. Roche expects the technology to increase speed and sensitivity in addition to lowing costs.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs